Ip. Janecka et al., CRANIAL BASE SURGERY RESULTS IN 183 PATIENTS (REPRINTED FROM OTOLARYNGOLOGY-HEAD NECK-SURGERY), Journal of neuro-oncology, 20(3), 1994, pp. 281-289
Objective - To learn about the effects of cranial base surgery. Design
- Cohort study with a mean follow-up of 30 months. Setting - Populati
on-based. Patients - A consecutive sample of 183 patients who underwen
t cranial base surgery; 118 patients had malignant skull base tumors,
majority were previously treated; 50 had benign tumors, 9 patients had
congenital malformations of the skull base; 3 patients had inflammato
ry lesions, and 3 had traumatic defects of the skull base. Main outcom
e measures - Disease-free interval and overall survival as well as rat
e of complications and functional status Intervention - Cranial base s
urgery was followed by radiotherapy (in previously untreated patients)
. Results - After completion of follow-up (30 months, mean), 30 (25.4%
) patients had died of their malignant tumors and 8 (6.8%) had died of
other causes. One patient (0.84%) was lost to follow-up. The overall
cancer survival without regard to histologic type was 67% (63% with no
evidence of disease). Among the patients who were treated for benign
neoplasm 72% were NED at a mean 39 months of follow-up. The group of p
atients with congenital malformations, inflammatory, and traumatic les
ions demonstrated successful correction of their pre-surgical problem
with skull base surgery. One patient (invasive aspergillosis) died of
disease. The overall surgical/medical mortality was 2%, complication r
ate was 33% and Karnofsky performance scale was improved or unchanged
postoperatively in 83% of patients. The average duration of surgery, n
umber of blood transfusions used and the length of the hospital stay w
as 10 hours, 3 units, and 15 days respectively. Conclusions - Cranial
base surgery is a valid surgical technique for cranial base affliction
s. In this study it was found to be beneficial in controlling benign a
s well as malignant disease and be the treatment of choice in selected
congenital malformations, trauma, and inflammatory lesions.